2 years ago

AG1478 Nutlin-3 Nilotinib

latforms have been validated
using a panel of tool compounds that have been reported to
inhibit crucial signaling proteins and pathways concerned in B
cell activation and/or displayed efficacy in models of
immune and inflam read more...